These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 30780828)

  • 21. Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.
    Boland CL; Degeeter M; Nuzum DS; Tzefos M
    Ann Pharmacother; 2013 Apr; 47(4):490-505. PubMed ID: 23548652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Effectiveness of Liraglutide in Association with Patients' Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study.
    Berkovic MC; Bilic-Curcic I; Herman Mahecic D; Gradiser M; Grgurevic M; Bozek T
    Diabetes Ther; 2017 Dec; 8(6):1297-1308. PubMed ID: 29076038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liraglutide: from clinical trials to clinical practice.
    Gough SC
    Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
    Gross B
    J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease.
    Liu Y; Jiang X; Chen X
    Lipids Health Dis; 2017 Dec; 16(1):227. PubMed ID: 29197387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liraglutide in type 2 diabetes mellitus.
    Baruah MP; Chaudhury T; Sethi BK; Dharmalingam M
    J Indian Med Assoc; 2012 May; 110(5):335-8. PubMed ID: 23360033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes.
    Nauck MA; Hompesch M; Filipczak R; Le TD; Zdravkovic M; Gumprecht J;
    Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):417-23. PubMed ID: 17039422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin degludec + liraglutide: a complementary combination.
    Stinkens K; Peene B; Mathieu C
    Expert Opin Biol Ther; 2016 Sep; 16(9):1171-7. PubMed ID: 27484310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide.
    Vedtofte L; Knop FK; Vilsbøll T
    Expert Rev Clin Pharmacol; 2015 May; 8(3):273-82. PubMed ID: 25816888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide in type 2 diabetes: from pharmacological development to clinical practice.
    Rossi MC; Nicolucci A
    Acta Biomed; 2009 Aug; 80(2):93-101. PubMed ID: 19848045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy of type 2 diabetes and cardiovascular prevention: potentials for liraglutide].
    Reboldi G
    G Ital Cardiol (Rome); 2009 Jul; 10(7):434-47. PubMed ID: 19761101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.
    Wang B; Roth JA; Nguyen H; Felber E; Furnback W; Garrison LP
    PLoS One; 2015; 10(4):e0121915. PubMed ID: 25849542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus.
    Scott LJ
    Drugs; 2014 Dec; 74(18):2161-74. PubMed ID: 25367717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dulaglutide: A Review in Type 2 Diabetes.
    Burness CB; Scott LJ
    BioDrugs; 2015 Dec; 29(6):407-18. PubMed ID: 26423061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives.
    Edavalath M; Stephens JW
    Patient Prefer Adherence; 2010 Mar; 4():61-8. PubMed ID: 20361006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting.
    Kaur P; Mahendru S; Mithal A
    Indian J Endocrinol Metab; 2016; 20(5):595-599. PubMed ID: 27730066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients.
    Zameer R; Kamin M; Raja U; Wahab MU; Ishtiaq O; Raashid K; Ahmed N; Rehman AU
    Cureus; 2020 Aug; 12(8):e9937. PubMed ID: 32864274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preference.
    Yabe D; Seino Y
    Clin Med Insights Endocrinol Diabetes; 2011; 4():47-62. PubMed ID: 22879794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date.
    Howell R; Wright AM; Clements JN
    Diabetes Metab Syndr Obes; 2019; 12():505-512. PubMed ID: 31118715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.